Tissue penetration of ciprofloxacin after single and multiple doses.
about
Pharmacokinetics of temafloxacin in humans after multiple oral dosesFocus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsMycobacteria and the new quinolonesBactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.Interaction between ciprofloxacin and rifampin.Ciprofloxacin activity in cyst fluid from polycystic kidneys.Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelPharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid.Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Fluoroquinolone antibiotics having the potential to interfere with fluorescence-based diagnosis.Levofloxacin for the treatment of pyelonephritis.A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans.Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Pharmacokinetics of a novel quinolone, AT-4140, in animals.Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects.Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin dispositionOptimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis.Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.Calculation of the antibiotic level in the lung tissue and bronchial secretion with an oral controlled-release dosage form.Disposition of ciprofloxacin following intravenous administration in dogs.
P2860
Q24679273-8360FA4E-7FE2-4D4F-871D-230187002253Q26746197-89B04FC0-61AF-495A-A566-BE1620675FEDQ28342507-3058661D-EC7D-4D42-A7BC-74DBB6C2B927Q30451758-49B82DE8-FE4B-4E56-800F-B76BD66F3670Q33722507-6F01AA44-40C4-43BC-A419-C5CF7AEBBD6FQ35308712-AD3B9E59-C06C-425D-BE26-C7A8BDB17D55Q35359695-120580B3-4B27-4FF8-BBA8-65B66E6D0FB5Q35541583-AD3352CD-6C23-4311-AE67-1889D1AF4EFFQ35651376-FF06DAE7-4CB6-4457-9472-3784E6B3BC97Q35822889-6EDF9D73-A9E1-4880-983B-9941252AE7A0Q35826273-79510823-AB82-4909-9944-5A88E0490A94Q36757684-02628752-2904-4751-9D71-50E3088009F7Q36863646-918037C3-0737-4E53-85C8-E90CBEE3B35AQ37008961-2B0709DD-F6FE-4F98-B76F-3E7BE1091879Q38101380-CE755359-CCFB-4579-BC75-18A9704ACFF7Q38582536-D543FD0E-4B38-47CB-96A4-9972556DE20CQ38663357-8EFE30E0-6C6C-44EB-A76C-FE5765692F07Q39214819-09EFB7F8-652C-43F8-9AF9-BF615A00409EQ39815188-6F3BA610-5200-48B4-85F2-5BB737DB7C70Q39820029-FA50334A-6D03-4641-A3BD-326E8CCC1AAAQ39828385-A293901C-0B85-46A0-91BB-E0A39A145409Q39832480-BD78D23D-B440-434D-97D3-80FD88FB6C82Q39881928-009B4F2A-A0A4-485E-8DE4-0E0447765001Q40744378-D5E68B76-5BBB-47B4-A57F-13EE1F7FD894Q44023516-0AB287DF-4D1C-4A19-9CCF-5885B1A10362Q44863085-A8F4CA33-6F2E-48AE-9785-B147EABAC53CQ50949982-74EE37C7-3BC5-4D20-BEB1-EEDF7813CF52Q54023008-F985CCF9-47EE-40D3-8A19-26F8B8885BED
P2860
Tissue penetration of ciprofloxacin after single and multiple doses.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Tissue penetration of ciprofloxacin after single and multiple doses.
@ast
Tissue penetration of ciprofloxacin after single and multiple doses.
@en
type
label
Tissue penetration of ciprofloxacin after single and multiple doses.
@ast
Tissue penetration of ciprofloxacin after single and multiple doses.
@en
prefLabel
Tissue penetration of ciprofloxacin after single and multiple doses.
@ast
Tissue penetration of ciprofloxacin after single and multiple doses.
@en
P2093
P2860
P356
P1476
Tissue penetration of ciprofloxacin after single and multiple doses.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.3.501
P407
P577
1986-03-01T00:00:00Z